Cellectis' Shareholders Meeting to be Held on December 22, 2023 | Region

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies,

Related Keywords

New York ,United States ,Raleigh ,North Carolina ,France ,Paris ,France General ,Annonces Legales Obligatoires ,Arthur Stril ,Ashleyr Robinson ,Patricia Sosa Navarro ,Nasdaq ,Euronext Growth ,Bulletin Des Annonces Legales Obligatoires ,Nasdaq Global Market ,Sosa Navarro ,Chief Business Officer ,Lifesci Advisors ,Region ,